Search Results

You are looking at 91 - 100 of 152 items for :

Clear All
Full access

James L. Mohler and Emmanuel S. Antonarakis

Testing Into Practice Results of somatic genomic testing can inform treatment in men with prostate cancer, explained Emmanuel S. Antonarakis, MD, Associate Professor of Oncology and Urology, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, and

Full access

Linda Overholser and Carlin Callaway

think we tend to simplify the relationship between primary care and oncology, as if there's only primary care and oncology,” she said. “But coordination, even from the beginning, often involves other specialists (endocrinology, urology, dermatology

Full access

Harry W. Herr

; 72 : 99 – 102 . 5. Dalbagni G Herr HW Reuter VE . Impact of a second transurethral resection on staging of T1 bladder cancer . Urology 2002 ; 60 : 822 – 825 . 6. Pycha Al . How to teach the teacher to teach the TUR-B . Int

Full access

Chunkit Fung, Paul C. Dinh Jr, Sophie D. Fossa and Lois B. Travis

metastatic testicular cancer . Urology 2009 ; 73 : 328 – 331 , discussion 331–332 . 10.1016/j.urology.2008.08.501 19022490 93. Dahl AA , Haaland CF , Mykletun A , . Study of anxiety disorder and depression in long-term survivors of testicular

Full access

representation from medical oncology, dermatology, gastroenterology, rheumatology, pulmonology, endocrinology, urology, neurology, hematology, emergency medicine, and nursing, as well as patient advocacy experts. The clinical recommendations are based on

Full access

the diagnosis and treatment of prostate cancer since the NCCN Guidelines were published in 1996,” said James L. Mohler, MD, Associate Director for Translational Research, Chair, Department of Urology, and Professor of Oncology, Roswell Park Cancer

Full access

Joshua I. Warrick

. Plasmacytoid bladder cancer: variant histology with aggressive behavior and a new mode of invasion along fascial planes . Urology 2014 ; 83 : 1112 – 1116 . 31. Kaimakliotis HZ Monn MF Cary KC . Plasmacytoid variant urothelial bladder cancer: is

Full access

Michelle L. McDonald and J. Kellogg Parsons

Cancer J Clin 2010 ; 60 : 70 – 98 . 42. Carroll P Coley C McLeod D . Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up . Urology 2001 ; 57 : 225 – 229 . 43. Vickers AJ

Full access

Natasha C. Townsend, Karen Ruth, Tahseen Al-Saleem, Eric M. Horwitz, Mark Sobczak, Robert G. Uzzo, Rosalia Viterbo and Mark K. Buyyounouski

prostatectomy specimens and prediction of high-grade Gleason patterns: significance of central pathologic review . Urology 2011 ; 77 : 407 – 411 . 24. D’Souza N Loblaw DA Mamedov A . Prostate cancer pathology audits: is central pathology review

Full access

Christopher J. Magnani, Kevin Li, Tina Seto, Kathryn M. McDonald, Douglas W. Blayney, James D. Brooks and Tina Hernandez-Boussard

, Karnes RJ , Gross CP , . Contemporary national trends of prostate cancer screening among privately insured men in the United States . Urology 2016 ; 97 : 111 – 117 . 10.1016/j.urology.2016.06.067 27527411 35. Gandaglia G , Briganti A